GLAS Stock Analysis: Glass House Brands | US
Drug Manufacturers - Specialty & Generic | US, USA | Market Cap: 1.007m USD | 12M Return: 3.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.04M
Rev. Trend: 55.4%
Warnings
Tailwinds
Seasonality 0.1 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Glass House Brands Inc. is a vertically integrated cannabis company operating in the United States with a focus on the California market. Its business is organized into three segments: Retail, which owns and operates cannabis dispensaries; Wholesale Biomass, which covers the cultivation, processing, and distribution of cannabis flower and trim; and Cannabis-Related Consumer Packaged Goods, which handles the manufacturing, extraction, and packaging of branded cannabis products for third-party retail stores.
The company sells its products under multiple brand names, including Glass House Farms, PLUS, Allswell, REEFORM, and Mama Sue, covering categories such as raw flower, pre-rolls, vapes, edibles, tinctures, and oil. In addition to wholesale distribution, Glass House provides ancillary services like online payment processing, in-store pickup, and home delivery to both adult-use and medicinal customers. Founded in 2015, the company is headquartered in Long Beach, California.
Vertical integration is a common structural model in the U.S. cannabis industry, driven in part by state-level regulations that often require separate licensing for cultivation, manufacturing, distribution, and retail activities. California, where Glass House concentrates its operations, represents the largest legal adult-use cannabis market in the United States following the passage of Proposition 64 in 2016.
- California wholesale cannabis prices remain depressed amid oversupply
- PLUS pre-roll brand drives CPG segment revenue growth
- Retail dispensary expansion boosts same-store sales momentum
| Net Income: -35.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.08 > 0.02 and ΔFCF/TA -14.05 > 1.0 |
| NWC/Revenue: 19.40% < 20% (prev 15.22%; Δ 4.18% < -1%) |
| CFO/TA -0.01 > 3% & CFO -2.78m > Net Income -35.1m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (84.7m) vs 12m ago 9.37% < -2% |
| Gross Margin: 39.83% > 18% (prev 48.48%; Δ -8.65% > 0.5%) |
| Asset Turnover: 55.27% > 50% (prev 64.48%; Δ -9.20% > 0%) |
| Interest Coverage Ratio: -4.48 > 6 (EBIT TTM -26.1m / Interest Expense TTM 5.83m) |
| A: 0.10 (Total Current Assets 74.4m - Total Current Liabilities 40.2m) / Total Assets 325.4m |
| B: -0.73 (Retained Earnings -237.2m / Total Assets 325.4m) |
| C: -0.08 (EBIT TTM -26.1m / Avg Total Assets 318.5m) |
| D: 1.20 (Book Value of Equity 177.4m / Total Liabilities 147.9m) |
| Altman-Z'' = -0.98 = CCC |
| DSRI: 1.10 (Receivables 6.44m/6.71m, Revenue 176.0m/200.9m) |
| GMI: 1.22 (GM 48.48% / 39.83%) |
| AQI: 0.74 (AQ_t 0.05 / AQ_t-1 0.06) |
| SGI: 0.88 (Revenue 176.0m / 200.9m) |
| TATA: -0.10 (NI -35.1m - CFO -2.78m) / TA 325.4m) |
| Beneish M = -3.00 (Cap -4..+1) = AA |
As of July 14, 2026, the stock is trading at USD 11.41 with a total of 195,479 shares traded. Over the past week, the price has changed by +0.97%, over one month by -12.23%, over three months by +3.63% and over the past year by +3.63%.
Current recommended Stop Loss: 10.00 (which is 12.4% or 1.7 ATR below the current price).
Glass House Brands has no consensus analysts rating.
P/E Forward = 263.1579
P/S = 5.6702
P/B = 11.86
Revenue TTM = 176.0m USD
EBIT TTM = -26.1m USD
EBITDA TTM = -10.2m USD
Long Term Debt = 67.8m USD (from longTermDebt, last quarter)
Short Term Debt = 38.0k USD (from shortLongTermDebt, last quarter)
Debt = 5.94m USD (Leases only: 5.94m)
Net Debt = -18.5m USD (calculated: Debt 5.94m - CCE 24.4m)
Enterprise Value = 989.0m USD (1.01b + Debt 5.94m - CCE 24.4m)
Interest Coverage Ratio = -4.48 (Ebit TTM -26.1m / Interest Expense TTM 5.83m)
EV/FCF = -36.89x (Enterprise Value 989.0m / FCF TTM -26.8m)
FCF Yield = -2.71% (FCF TTM -26.8m / Enterprise Value 989.0m)
FCF Margin = -15.23% (FCF TTM -26.8m / Revenue TTM 176.0m)
Net Margin = -19.94% (Net Income TTM -35.1m / Revenue TTM 176.0m)
Gross Margin = 39.83% ((Revenue TTM 176.0m - Cost of Revenue TTM 105.9m) / Revenue TTM)
Gross Margin QoQ = 33.99% (prev 33.99%)
Tobins Q-Ratio = 3.04 (Enterprise Value 989.0m / Total Assets 325.4m)
Interest Expense / Debt = 98.01% (Interest Expense 5.83m / Debt 5.94m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -20.6m (EBIT -26.1m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.85 (Total Current Assets 74.4m / Total Current Liabilities 40.2m)
Debt / Equity = 0.03 (Debt 5.94m / totalStockholderEquity, last quarter 177.4m)
Debt / EBITDA = 1.82 (negative EBITDA) (Net Debt -18.5m / EBITDA -10.2m)
Debt / FCF = 0.69 (negative FCF - burning cash) (Net Debt -18.5m / FCF TTM -26.8m)
Total Stockholder Equity = 119.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -11.02% (Net Income -35.1m / Total Assets 325.4m)
RoE = -29.35% (Net Income TTM -35.1m / Total Stockholder Equity 119.6m)
RoCE = -13.93% (EBIT -26.1m / Capital Employed (Equity 119.6m + L.T.Debt 67.8m))
RoIC = -7.46% (negative operating profit) (NOPAT -20.6m / Invested Capital 276.3m)
WACC = 0.0% (E(1.01b)/V(1.01b) * Re(0.0%) + (debt cost/tax rate unavailable))
Discount Rate = 5.29% (= Risk Free + ERP)
[DCF] Fair Price = unknown (Cash Flow -26.8m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 55.43 | Revenue CAGR: 6.37% | SUE: N/A | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.06 | Chg30d=N/A | Revisions=+0% | Analysts=2
EPS current Year (2026-12-31): EPS=-0.12 | Chg30d=+28.57% | Revisions=-25% | GrowthEPS=+43.7% | GrowthRev=+17.2%
EPS next Year (2027-12-31): EPS=0.27 | Chg30d=+152.38% | Revisions=+0% | GrowthEPS=+312.0% | GrowthRev=+22.0%
[Analyst] Revisions Ratio: -25% (up=0, down=1)